| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.77e-07 | 20 | 51 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 2.09e-06 | 36 | 51 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 6.60e-06 | 279 | 51 | 7 | GO:0005096 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 6.99e-06 | 398 | 51 | 8 | GO:0061659 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 7.97e-06 | 50 | 51 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.01e-05 | 53 | 51 | 4 | GO:0016859 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 3.99e-05 | 507 | 51 | 8 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 3.99e-05 | 507 | 51 | 8 | GO:0030695 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 4.27e-05 | 512 | 51 | 8 | GO:0019787 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 5.60e-05 | 532 | 51 | 8 | GO:0016755 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 7.20e-04 | 775 | 51 | 8 | GO:0016746 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 1.32e-03 | 656 | 51 | 7 | GO:0008047 | |
| GeneOntologyMolecularFunction | small GTPase binding | 1.33e-03 | 321 | 51 | 5 | GO:0031267 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.38e-03 | 86 | 51 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | isomerase activity | 1.45e-03 | 192 | 51 | 4 | GO:0016853 | |
| GeneOntologyMolecularFunction | R-SMAD binding | 2.00e-03 | 26 | 51 | 2 | GO:0070412 | |
| GeneOntologyMolecularFunction | GTPase binding | 2.20e-03 | 360 | 51 | 5 | GO:0051020 | |
| GeneOntologyMolecularFunction | molecular function activator activity | 3.67e-03 | 1233 | 51 | 9 | GO:0140677 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.14e-09 | 20 | 51 | 5 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 4.14e-09 | 9 | 51 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 6.89e-09 | 10 | 51 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 2.33e-08 | 13 | 51 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 3.26e-08 | 14 | 51 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 2.30e-06 | 38 | 51 | 4 | GO:0000413 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 8.36e-06 | 195 | 51 | 6 | GO:0006606 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 9.57e-06 | 54 | 51 | 4 | GO:0018208 | |
| GeneOntologyBiologicalProcess | import into nucleus | 9.94e-06 | 201 | 51 | 6 | GO:0051170 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 1.85e-05 | 132 | 51 | 5 | GO:0043255 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 2.85e-05 | 71 | 51 | 4 | GO:0006111 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 1.63e-04 | 111 | 51 | 4 | GO:0006094 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 1.87e-04 | 115 | 51 | 4 | GO:0019319 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 2.28e-04 | 121 | 51 | 4 | GO:0046364 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 2.59e-04 | 362 | 51 | 6 | GO:0034504 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 2.61e-04 | 231 | 51 | 5 | GO:0006109 | |
| GeneOntologyBiologicalProcess | negative regulation of protein autophosphorylation | 3.25e-04 | 11 | 51 | 2 | GO:0031953 | |
| GeneOntologyBiologicalProcess | nuclear transport | 3.27e-04 | 378 | 51 | 6 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 3.27e-04 | 378 | 51 | 6 | GO:0006913 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 3.36e-04 | 134 | 51 | 4 | GO:0010906 | |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | 3.54e-04 | 247 | 51 | 5 | GO:0016051 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | 4.29e-04 | 740 | 51 | 8 | GO:0006886 | |
| GeneOntologyBiologicalProcess | mRNA transport | 4.53e-04 | 145 | 51 | 4 | GO:0051028 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 4.71e-04 | 405 | 51 | 6 | GO:0033674 | |
| GeneOntologyBiologicalProcess | RNA transport | 9.17e-04 | 175 | 51 | 4 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 9.17e-04 | 175 | 51 | 4 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 9.77e-04 | 178 | 51 | 4 | GO:0051236 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.54e-09 | 21 | 52 | 5 | GO:0106068 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.37e-09 | 8 | 52 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 7.07e-09 | 10 | 52 | 4 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 3.34e-08 | 14 | 52 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.02e-07 | 18 | 52 | 4 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.60e-07 | 20 | 52 | 4 | GO:0042405 | |
| GeneOntologyCellularComponent | nuclear pore | 5.17e-06 | 101 | 52 | 5 | GO:0005643 | |
| GeneOntologyCellularComponent | transcription factor AP-1 complex | 6.04e-05 | 5 | 52 | 2 | GO:0035976 | |
| GeneOntologyCellularComponent | inclusion body | 7.43e-05 | 90 | 52 | 4 | GO:0016234 | |
| GeneOntologyCellularComponent | transferase complex | RGPD2 RANBP2 DCAF4L2 RGPD8 RGPD1 UBR3 BOD1L1 ZYG11B FBXL19 SMC5 | 1.11e-04 | 963 | 52 | 10 | GO:1990234 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD2 JUN RANBP2 RGPD8 FOS RGPD1 BOD1L1 MTREX ATF6B CREM RGPD5 | 4.79e-04 | 1377 | 52 | 11 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear envelope | 2.58e-03 | 560 | 52 | 6 | GO:0005635 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 8.25e-08 | 16 | 38 | 4 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 6.65e-07 | 26 | 38 | 4 | MP:0012058 | |
| MousePheno | decreased tumor latency | 1.21e-06 | 30 | 38 | 4 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 1.39e-06 | 31 | 38 | 4 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 2.03e-06 | 34 | 38 | 4 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 3.57e-06 | 39 | 38 | 4 | MP:0012128 | |
| MousePheno | abnormal rod electrophysiology | 1.65e-05 | 119 | 38 | 5 | MP:0004021 | |
| MousePheno | aneuploidy | 2.17e-05 | 61 | 38 | 4 | MP:0004024 | |
| MousePheno | abnormal eye electrophysiology | 3.14e-05 | 228 | 38 | 6 | MP:0005551 | |
| MousePheno | increased hepatocellular carcinoma incidence | 3.74e-05 | 70 | 38 | 4 | MP:0003331 | |
| MousePheno | increased lung carcinoma incidence | 5.73e-05 | 78 | 38 | 4 | MP:0008714 | |
| MousePheno | abnormal chromosome number | 8.40e-05 | 86 | 38 | 4 | MP:0004023 | |
| MousePheno | enlarged epididymis | 1.45e-04 | 99 | 38 | 4 | MP:0004931 | |
| MousePheno | increased sarcoma incidence | 1.63e-04 | 102 | 38 | 4 | MP:0002032 | |
| MousePheno | increased lung tumor incidence | 1.96e-04 | 107 | 38 | 4 | MP:0008014 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 1.96e-04 | 107 | 38 | 4 | MP:0003694 | |
| MousePheno | increased respiratory system tumor incidence | 1.96e-04 | 107 | 38 | 4 | MP:0010298 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 2.09e-04 | 203 | 38 | 5 | MP:0011094 | |
| MousePheno | increased liver tumor incidence | 2.26e-04 | 111 | 38 | 4 | MP:0008019 | |
| MousePheno | increased hepatobiliary system tumor incidence | 2.26e-04 | 111 | 38 | 4 | MP:0010297 | |
| MousePheno | abnormal blastocyst hatching | 2.42e-04 | 113 | 38 | 4 | MP:0003693 | |
| MousePheno | abnormal chromosome morphology | 3.66e-04 | 126 | 38 | 4 | MP:0003702 | |
| MousePheno | abnormal mitosis | 3.89e-04 | 128 | 38 | 4 | MP:0004046 | |
| MousePheno | embryonic lethality before implantation | 4.70e-04 | 242 | 38 | 5 | MP:0006204 | |
| MousePheno | increased incidence of tumors by chemical induction | 5.61e-04 | 141 | 38 | 4 | MP:0004499 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 9.01e-04 | 160 | 38 | 4 | MP:0005659 | |
| MousePheno | abnormal epididymis size | 1.03e-03 | 166 | 38 | 4 | MP:0004926 | |
| MousePheno | abnormal preimplantation embryo development | 1.15e-03 | 171 | 38 | 4 | MP:0009781 | |
| MousePheno | increased incidence of induced tumors | 1.20e-03 | 173 | 38 | 4 | MP:0002021 | |
| Domain | Ran_BP1 | 7.87e-11 | 12 | 49 | 5 | PF00638 | |
| Domain | RANBD1 | 7.87e-11 | 12 | 49 | 5 | PS50196 | |
| Domain | RanBD | 1.28e-10 | 13 | 49 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 1.28e-10 | 13 | 49 | 5 | IPR000156 | |
| Domain | Grip | 1.36e-08 | 11 | 49 | 4 | SM00755 | |
| Domain | GRIP | 1.36e-08 | 11 | 49 | 4 | PF01465 | |
| Domain | GRIP_dom | 2.04e-08 | 12 | 49 | 4 | IPR000237 | |
| Domain | GRIP | 2.04e-08 | 12 | 49 | 4 | PS50913 | |
| Domain | GCC2_Rab_bind | 5.90e-07 | 7 | 49 | 3 | IPR032023 | |
| Domain | Rab_bind | 5.90e-07 | 7 | 49 | 3 | PF16704 | |
| Domain | bZIP_1 | 1.83e-06 | 34 | 49 | 4 | PF00170 | |
| Domain | - | 2.01e-06 | 10 | 49 | 3 | 1.10.220.60 | |
| Domain | TF_DNA-bd | 2.59e-06 | 37 | 49 | 4 | IPR008917 | |
| Domain | BRLZ | 1.03e-05 | 52 | 49 | 4 | SM00338 | |
| Domain | BZIP | 1.11e-05 | 53 | 49 | 4 | PS50217 | |
| Domain | BZIP_BASIC | 1.11e-05 | 53 | 49 | 4 | PS00036 | |
| Domain | bZIP | 1.20e-05 | 54 | 49 | 4 | IPR004827 | |
| Domain | TPR-contain_dom | 4.48e-05 | 150 | 49 | 5 | IPR013026 | |
| Domain | TPR_REGION | 7.05e-05 | 165 | 49 | 5 | PS50293 | |
| Domain | TPR | 7.05e-05 | 165 | 49 | 5 | PS50005 | |
| Domain | TPR_1 | 9.05e-05 | 90 | 49 | 4 | PF00515 | |
| Domain | TPR_1 | 9.05e-05 | 90 | 49 | 4 | IPR001440 | |
| Domain | TPR-like_helical_dom | 3.53e-04 | 233 | 49 | 5 | IPR011990 | |
| Domain | TPR | 3.62e-04 | 129 | 49 | 4 | SM00028 | |
| Domain | TPR_repeat | 4.06e-04 | 133 | 49 | 4 | IPR019734 | |
| Domain | PH_dom-like | 8.29e-04 | 426 | 49 | 6 | IPR011993 | |
| Domain | IQ | 1.25e-03 | 81 | 49 | 3 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.70e-03 | 90 | 49 | 3 | IPR000048 | |
| Domain | IQ | 1.87e-03 | 93 | 49 | 3 | PS50096 | |
| Domain | - | 2.10e-03 | 207 | 49 | 4 | 1.25.40.10 | |
| Domain | - | 3.51e-03 | 391 | 49 | 5 | 2.30.29.30 | |
| Domain | Leu-rich_rpt | 5.50e-03 | 271 | 49 | 4 | IPR001611 | |
| Domain | - | 6.28e-03 | 449 | 49 | 5 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 6.88e-03 | 459 | 49 | 5 | IPR013083 | |
| Domain | ZF_RING_1 | 7.05e-03 | 291 | 49 | 4 | PS00518 | |
| Domain | ZF_RING_2 | 7.66e-03 | 298 | 49 | 4 | PS50089 | |
| Domain | zf-RING_2 | 8.22e-03 | 52 | 49 | 2 | PF13639 | |
| Domain | - | 9.88e-03 | 321 | 49 | 4 | 3.80.10.10 | |
| Domain | HEAT | 1.02e-02 | 58 | 49 | 2 | IPR000357 | |
| Domain | Znf_RING | 1.04e-02 | 326 | 49 | 4 | IPR001841 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 6.54e-08 | 18 | 32 | 4 | MM1549 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 7.72e-08 | 49 | 32 | 5 | MM14837 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.18e-06 | 84 | 32 | 5 | MM14929 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.89e-06 | 40 | 32 | 4 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.09e-06 | 41 | 32 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.30e-06 | 42 | 32 | 4 | MM15039 | |
| Pathway | BIOCARTA_DREAM_PATHWAY | 2.31e-06 | 12 | 32 | 3 | MM1475 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.54e-06 | 43 | 32 | 4 | MM14609 | |
| Pathway | BIOCARTA_DREAM_PATHWAY | 2.99e-06 | 13 | 32 | 3 | M18899 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 3.64e-06 | 47 | 32 | 4 | MM14939 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 4.68e-06 | 50 | 32 | 4 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 5.07e-06 | 51 | 32 | 4 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 6.88e-06 | 55 | 32 | 4 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 8.51e-06 | 58 | 32 | 4 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 8.51e-06 | 58 | 32 | 4 | MM14736 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 1.26e-05 | 505 | 32 | 8 | MM15548 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.34e-05 | 65 | 32 | 4 | MM15147 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.13e-05 | 73 | 32 | 4 | MM14948 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 3.38e-05 | 82 | 32 | 4 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION | 3.62e-05 | 169 | 32 | 5 | MM14919 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 4.08e-05 | 86 | 32 | 4 | MM15413 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_ERK_SIGNALING_PATHWAY | 4.97e-05 | 5 | 32 | 2 | M49004 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_VPR_TAT_TO_TNF_JNK_SIGNALING_PATHWAY | 4.97e-05 | 5 | 32 | 2 | M47570 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 5.31e-05 | 92 | 32 | 4 | MM14951 | |
| Pathway | REACTOME_SIGNALING_BY_ALK_IN_CANCER | 5.54e-05 | 93 | 32 | 4 | M42521 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 7.21e-05 | 36 | 32 | 3 | M39908 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 7.36e-05 | 100 | 32 | 4 | MM14561 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 8.45e-05 | 202 | 32 | 5 | MM15362 | |
| Pathway | BIOCARTA_TSP1_PATHWAY | 1.04e-04 | 7 | 32 | 2 | M22039 | |
| Pathway | BIOCARTA_TSP1_PATHWAY | 1.04e-04 | 7 | 32 | 2 | MM1559 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.22e-04 | 114 | 32 | 4 | MM15361 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 1.35e-04 | 117 | 32 | 4 | MM15387 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_JNK_SIGNALING_PATHWAY | 1.39e-04 | 8 | 32 | 2 | M47814 | |
| Pathway | WP_SELENIUM_METABOLISM_SELENOPROTEINS | 1.41e-04 | 45 | 32 | 3 | MM15877 | |
| Pathway | WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS | 1.61e-04 | 47 | 32 | 3 | M48301 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.97e-04 | 129 | 32 | 4 | MM14894 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.22e-04 | 10 | 32 | 2 | MM15135 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.22e-04 | 10 | 32 | 2 | M13962 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 2.77e-04 | 141 | 32 | 4 | MM15266 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY | 3.25e-04 | 12 | 32 | 2 | M47597 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350 | 3.25e-04 | 12 | 32 | 2 | M47798 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 3.25e-04 | 12 | 32 | 2 | M47815 | |
| Pathway | WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION | 3.67e-04 | 62 | 32 | 3 | M39429 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 3.68e-04 | 277 | 32 | 5 | MM15414 | |
| Pathway | WP_NEUROINFLAMMATION | 3.83e-04 | 13 | 32 | 2 | M39895 | |
| Pathway | PID_BCR_5PATHWAY | 3.85e-04 | 63 | 32 | 3 | M10 | |
| Pathway | BIOCARTA_CDMAC_PATHWAY | 5.15e-04 | 15 | 32 | 2 | MM1358 | |
| Pathway | WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER | 5.87e-04 | 16 | 32 | 2 | M39882 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TNF_JNK_SIGNALING_PATHWAY | 5.87e-04 | 16 | 32 | 2 | M47569 | |
| Pathway | BIOCARTA_CDMAC_PATHWAY | 5.87e-04 | 16 | 32 | 2 | M4388 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 5.87e-04 | 16 | 32 | 2 | M47801 | |
| Pathway | WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS | 5.87e-04 | 16 | 32 | 2 | M42567 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 6.65e-04 | 17 | 32 | 2 | M2349 | |
| Pathway | BIOCARTA_ETS_PATHWAY | 6.65e-04 | 17 | 32 | 2 | M14449 | |
| Pathway | BIOCARTA_ETS_PATHWAY | 6.65e-04 | 17 | 32 | 2 | MM1435 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 6.67e-04 | 76 | 32 | 3 | MM1433 | |
| Pathway | BIOCARTA_CARDIACEGF_PATHWAY | 7.47e-04 | 18 | 32 | 2 | MM1479 | |
| Pathway | BIOCARTA_CARDIACEGF_PATHWAY | 7.47e-04 | 18 | 32 | 2 | M7552 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 8.04e-04 | 81 | 32 | 3 | M13863 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 8.33e-04 | 19 | 32 | 2 | MM1453 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 8.33e-04 | 19 | 32 | 2 | M47793 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL1_IL1R_JNK_SIGNALING_PATHWAY | 8.33e-04 | 19 | 32 | 2 | M47471 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 8.33e-04 | 19 | 32 | 2 | M12836 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 9.07e-04 | 193 | 32 | 4 | MM14890 | |
| Pathway | BIOCARTA_ARENRF2_PATHWAY | 9.25e-04 | 20 | 32 | 2 | M14339 | |
| Pathway | BIOCARTA_NGF_PATHWAY | 9.25e-04 | 20 | 32 | 2 | M7860 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 9.25e-04 | 20 | 32 | 2 | MM1389 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 9.25e-04 | 85 | 32 | 3 | M48315 | |
| Pathway | BIOCARTA_IL6_PATHWAY | 1.02e-03 | 21 | 32 | 2 | M5489 | |
| Pathway | BIOCARTA_IGF1_PATHWAY | 1.02e-03 | 21 | 32 | 2 | M2623 | |
| Pathway | BIOCARTA_INSULIN_PATHWAY | 1.02e-03 | 21 | 32 | 2 | M765 | |
| Pathway | WP_TCELL_ACTIVATION_SARSCOV2 | 1.02e-03 | 88 | 32 | 3 | M42580 | |
| Pathway | BIOCARTA_ARENRF2_PATHWAY | 1.12e-03 | 22 | 32 | 2 | MM1449 | |
| Pathway | PID_PDGFRA_PATHWAY | 1.12e-03 | 22 | 32 | 2 | M206 | |
| Pathway | BIOCARTA_IGF1_PATHWAY | 1.12e-03 | 22 | 32 | 2 | MM1409 | |
| Pathway | BIOCARTA_IL6_PATHWAY | 1.12e-03 | 22 | 32 | 2 | MM1415 | |
| Pathway | BIOCARTA_NGF_PATHWAY | 1.12e-03 | 22 | 32 | 2 | MM1440 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 1.12e-03 | 22 | 32 | 2 | M7747 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 1.23e-03 | 23 | 32 | 2 | MM1411 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 1.23e-03 | 23 | 32 | 2 | MM1424 | |
| Pathway | WP_ESTROGEN_SIGNALING | 1.23e-03 | 23 | 32 | 2 | M39672 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 1.23e-03 | 23 | 32 | 2 | M7897 | |
| Pathway | WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING | 1.23e-03 | 23 | 32 | 2 | M39709 | |
| Pathway | WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART | 1.34e-03 | 24 | 32 | 2 | M39576 | |
| Pathway | BIOCARTA_INSULIN_PATHWAY | 1.34e-03 | 24 | 32 | 2 | MM1425 | |
| Pathway | PID_S1P_S1P2_PATHWAY | 1.34e-03 | 24 | 32 | 2 | M268 | |
| Pathway | BIOCARTA_TOLL_PATHWAY | 1.34e-03 | 24 | 32 | 2 | MM1518 | |
| Pathway | SA_B_CELL_RECEPTOR_COMPLEXES | 1.34e-03 | 24 | 32 | 2 | M17200 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 1.34e-03 | 24 | 32 | 2 | M11520 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 1.45e-03 | 25 | 32 | 2 | MM1519 | |
| Pathway | WP_NOVEL_JUNDMP1_PATHWAY | 1.45e-03 | 25 | 32 | 2 | MM15984 | |
| Pathway | BIOCARTA_TOLL_PATHWAY | 1.45e-03 | 25 | 32 | 2 | M984 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY | 1.57e-03 | 26 | 32 | 2 | M47565 | |
| Pathway | REACTOME_M_PHASE | 1.66e-03 | 387 | 32 | 5 | MM15364 | |
| Pathway | BIOCARTA_EGF_PATHWAY | 1.69e-03 | 27 | 32 | 2 | M1909 | |
| Pathway | PID_TCR_CALCIUM_PATHWAY | 1.82e-03 | 28 | 32 | 2 | M235 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 1.82e-03 | 28 | 32 | 2 | MM15132 | |
| Pathway | BIOCARTA_EGF_PATHWAY | 1.82e-03 | 28 | 32 | 2 | MM1386 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 1.82e-03 | 28 | 32 | 2 | M2529 | |
| Pathway | KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY | 1.85e-03 | 108 | 32 | 3 | M9904 | |
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 21205196 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 18949001 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 25187515 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 9037092 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 8603673 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.55e-10 | 7 | 52 | 4 | 15710750 | |
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 26632511 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 24403063 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.55e-10 | 7 | 52 | 4 | 11353387 | |
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 30944974 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 38838144 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.55e-10 | 7 | 52 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.55e-10 | 7 | 52 | 4 | 17372272 | |
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 38657106 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 12191015 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 22821000 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 20682751 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 3.10e-10 | 8 | 52 | 4 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 3.10e-10 | 8 | 52 | 4 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 3.10e-10 | 8 | 52 | 4 | 28745977 | |
| Pubmed | 3.10e-10 | 8 | 52 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 3.10e-10 | 8 | 52 | 4 | 21310149 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 5.57e-10 | 9 | 52 | 4 | 18394993 | |
| Pubmed | 5.57e-10 | 9 | 52 | 4 | 11553612 | ||
| Pubmed | 5.57e-10 | 9 | 52 | 4 | 10601307 | ||
| Pubmed | 5.57e-10 | 9 | 52 | 4 | 9733766 | ||
| Pubmed | 5.57e-10 | 9 | 52 | 4 | 28100513 | ||
| Pubmed | 5.57e-10 | 9 | 52 | 4 | 28877029 | ||
| Pubmed | 5.57e-10 | 9 | 52 | 4 | 17887960 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 9.27e-10 | 10 | 52 | 4 | 8857542 | |
| Pubmed | 9.27e-10 | 10 | 52 | 4 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 9.27e-10 | 10 | 52 | 4 | 16332688 | |
| Pubmed | 9.27e-10 | 10 | 52 | 4 | 21859863 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.45e-09 | 11 | 52 | 4 | 35771867 | |
| Pubmed | 1.45e-09 | 11 | 52 | 4 | 17069463 | ||
| Pubmed | 1.45e-09 | 11 | 52 | 4 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 3.14e-09 | 13 | 52 | 4 | 31427429 | |
| Pubmed | 5.99e-09 | 15 | 52 | 4 | 14697343 | ||
| Pubmed | 1.26e-08 | 4 | 52 | 3 | 9480752 | ||
| Pubmed | 3.19e-08 | 22 | 52 | 4 | 27717094 | ||
| Pubmed | RGPD2 RANBP2 AGO1 RGPD8 LRRC24 RGPD1 PPP1R3F MPDZ PLEKHA5 DCTN1 ATF6B | 1.48e-07 | 963 | 52 | 11 | 28671696 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 3.16e-07 | 38 | 52 | 4 | 12791264 | |
| Pubmed | IQCF5 CEP104 RGPD2 RANBP2 CCDC185 RGPD8 SPEF2 RGPD1 BOD1L1 DCTN1 CXorf65 RGPD5 | 1.09e-06 | 1442 | 52 | 12 | 35575683 | |
| Pubmed | Expression of AP-1 (c-fos/c-jun) in developing mouse corneal epithelium. | 2.19e-06 | 2 | 52 | 2 | 12719996 | |
| Pubmed | RanBP2/Nup358 enhances miRNA activity by sumoylating Argonautes. | 2.19e-06 | 2 | 52 | 2 | 33600493 | |
| Pubmed | Integrative epigenomic profiling reveal AP-1 is a key regulator in intrahepatich cholangiocarcinoma. | 2.19e-06 | 2 | 52 | 2 | 34942351 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 8082881 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 20976196 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 33308098 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 19215067 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 23396363 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 20410304 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 7955078 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 38517374 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 8777432 | ||
| Pubmed | A regulatory element within a coding exon modulates keratin 18 gene expression in transgenic mice. | 2.19e-06 | 2 | 52 | 2 | 9346889 | |
| Pubmed | [Growth factors may enhance c-fos and c-jun gene expressions of hepatic stellate cells]. | 2.19e-06 | 2 | 52 | 2 | 19105933 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 21496208 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 17066317 | ||
| Pubmed | Platelet-activating factor induction of activator protein-1 signaling in bronchial epithelial cells. | 2.19e-06 | 2 | 52 | 2 | 9443941 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 30315111 | ||
| Pubmed | Thermodynamic analysis of Jun-Fos coiled coil peptide antagonists. | 2.19e-06 | 2 | 52 | 2 | 21199371 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 22719067 | ||
| Pubmed | A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation. | 2.19e-06 | 2 | 52 | 2 | 15944271 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 19921846 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 18316037 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 12547826 | ||
| Pubmed | AP1 enhances polyomavirus DNA replication by promoting T-antigen-mediated unwinding of DNA. | 2.19e-06 | 2 | 52 | 2 | 8763994 | |
| Pubmed | Genome-wide studies highlight indirect links between human replication origins and gene regulation. | 2.19e-06 | 2 | 52 | 2 | 18838675 | |
| Pubmed | AP1 transcription factors are required to maintain the peripheral taste system. | 2.19e-06 | 2 | 52 | 2 | 27787515 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 20111900 | ||
| Pubmed | Ap-1 recognizes sequence elements on hiv-1 LTR in human epithelial tumor-cell lines. | 2.19e-06 | 2 | 52 | 2 | 21607373 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 8793856 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 34671206 | ||
| Pubmed | [Effects of acrylamide on the protein expressions of c-fos and c-jun proto-oncogenes in cell L-02]. | 2.19e-06 | 2 | 52 | 2 | 20459032 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 15733037 | ||
| Pubmed | AFos dissociates cardiac myocyte hypertrophy and expression of the pathological gene program. | 2.19e-06 | 2 | 52 | 2 | 15795322 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 7476995 | ||
| Pubmed | Nuclear import of c-Jun is mediated by multiple transport receptors. | 2.19e-06 | 2 | 52 | 2 | 17652081 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 18621151 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 16002216 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 12692226 | ||
| Pubmed | AP-1 is a regulatory transcription factor of inflammaging in the murine kidney and liver. | 2.19e-06 | 2 | 52 | 2 | 37154113 | |
| Pubmed | The AP-1 transcription factor c-Jun prevents stress-imposed maladaptive remodeling of the heart. | 2.19e-06 | 2 | 52 | 2 | 24039904 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 12183893 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 8150544 | ||
| Pubmed | Memory processing and apamin induce immediate early gene expression in mouse brain. | 2.19e-06 | 2 | 52 | 2 | 8479285 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 23625009 | ||
| Pubmed | Fos and jun proteins are specifically expressed during differentiation of human keratinocytes. | 2.19e-06 | 2 | 52 | 2 | 15654976 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 15292661 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 11923421 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 27102414 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 25077945 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 21757709 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 21106746 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 19513521 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 8565820 | ||
| Pubmed | HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells. | 2.19e-06 | 2 | 52 | 2 | 8480425 | |
| Interaction | RGPD4 interactions | 2.16e-09 | 22 | 51 | 5 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 6.57e-09 | 27 | 51 | 5 | int:RGPD2 | |
| Interaction | NPIPB6 interactions | 1.08e-07 | 18 | 51 | 4 | int:NPIPB6 | |
| Interaction | RGPD3 interactions | 1.20e-07 | 47 | 51 | 5 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 1.49e-07 | 49 | 51 | 5 | int:RGPD1 | |
| Interaction | RGPD8 interactions | 1.20e-06 | 74 | 51 | 5 | int:RGPD8 | |
| Interaction | RGPD5 interactions | 4.36e-06 | 96 | 51 | 5 | int:RGPD5 | |
| Interaction | RANGAP1 interactions | 1.34e-05 | 314 | 51 | 7 | int:RANGAP1 | |
| Interaction | ESRP1 interactions | 4.30e-05 | 77 | 51 | 4 | int:ESRP1 | |
| Interaction | CXorf65 interactions | 6.25e-05 | 5 | 51 | 2 | int:CXorf65 | |
| Interaction | NEMP1 interactions | 7.58e-05 | 89 | 51 | 4 | int:NEMP1 | |
| Interaction | SUMO1 interactions | 8.32e-05 | 287 | 51 | 6 | int:SUMO1 | |
| Interaction | IQCF5 interactions | 9.36e-05 | 6 | 51 | 2 | int:IQCF5 | |
| Interaction | MLLT6 interactions | 9.77e-05 | 95 | 51 | 4 | int:MLLT6 | |
| Interaction | NFAT5 interactions | 1.21e-04 | 38 | 51 | 3 | int:NFAT5 | |
| Interaction | RCC1 interactions | 1.52e-04 | 201 | 51 | 5 | int:RCC1 | |
| Interaction | KLC3 interactions | 1.72e-04 | 110 | 51 | 4 | int:KLC3 | |
| Interaction | PHOX2A interactions | 1.74e-04 | 8 | 51 | 2 | int:PHOX2A | |
| Interaction | RAN interactions | 1.83e-04 | 475 | 51 | 7 | int:RAN | |
| Interaction | MTCL2 interactions | 1.98e-04 | 114 | 51 | 4 | int:MTCL2 | |
| Interaction | NUP50 interactions | 2.13e-04 | 341 | 51 | 6 | int:NUP50 | |
| Interaction | NR2F6 interactions | 2.15e-04 | 46 | 51 | 3 | int:NR2F6 | |
| Interaction | BARX2 interactions | 2.79e-04 | 10 | 51 | 2 | int:BARX2 | |
| Interaction | RANBP2 interactions | 2.89e-04 | 361 | 51 | 6 | int:RANBP2 | |
| Interaction | CCDC92 interactions | 3.27e-04 | 53 | 51 | 3 | int:CCDC92 | |
| GeneFamily | Basic leucine zipper proteins | 4.05e-06 | 49 | 40 | 4 | 506 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.25e-06 | 115 | 40 | 5 | 769 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 3.54e-07 | 474 | 52 | 9 | M40991 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 5.40e-07 | 33 | 52 | 4 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 1.60e-06 | 43 | 52 | 4 | MM3857 | |
| Coexpression | GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 2.78e-06 | 200 | 52 | 6 | M297 | |
| Coexpression | ONO_FOXP3_TARGETS_UP | 1.27e-05 | 23 | 52 | 3 | M1981 | |
| Coexpression | ONO_FOXP3_TARGETS_UP | 1.45e-05 | 24 | 52 | 3 | MM1270 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP | 2.46e-05 | 174 | 52 | 5 | M2038 | |
| Coexpression | GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP | 4.45e-05 | 197 | 52 | 5 | M3343 | |
| Coexpression | GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 4.67e-05 | 199 | 52 | 5 | M8381 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_UP | 4.78e-05 | 200 | 52 | 5 | M6016 | |
| Coexpression | CHASSOT_SKIN_WOUND | 1.38e-04 | 9 | 52 | 2 | M13038 | |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 1.72e-04 | 10 | 52 | 2 | MM1243 | |
| Coexpression | RADAEVA_RESPONSE_TO_IFNA1_DN | 1.72e-04 | 10 | 52 | 2 | M19208 | |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 1.72e-04 | 10 | 52 | 2 | M15228 | |
| Coexpression | JIANG_MELANOMA_TRM2_CD8 | 2.03e-04 | 146 | 52 | 4 | M48966 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 182 | 52 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 182 | 52 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV5/7_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.75e-06 | 189 | 52 | 5 | c8cfdc928ec29262f94ef3362a3f854716792a79 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-05 | 143 | 52 | 4 | 091708a47ac55c6585923ee30190ff296fa87f6f | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.48e-05 | 158 | 52 | 4 | ad0e2371c0bc6e53d22518aa3a401cddcde3759f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 162 | 52 | 4 | 04a96442e0fcdb6a65b9e45044021677f9f53d38 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 162 | 52 | 4 | 7adb3e279526e1f21033c10af0a0058258f21842 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 162 | 52 | 4 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-05 | 169 | 52 | 4 | 149a4f83da15bdeb170e980fb5b5b1af89ae07a6 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.62e-05 | 170 | 52 | 4 | bf589c4297ccc90e5f51e3d0fcc229548af4fcef | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.18e-05 | 175 | 52 | 4 | f456d8d958b71f7a942b718605712593d9de1bfd | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-Treg|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.29e-05 | 176 | 52 | 4 | 88247142c6482f3b4fa845d64e6189c690a5ee52 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-cDC2|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.53e-05 | 178 | 52 | 4 | 32120936a524c38e621bd2fca17524fef74422e0 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 5.65e-05 | 179 | 52 | 4 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.56e-05 | 186 | 52 | 4 | ed9b1a784f67e8a297e2a10993a6d97df60581ac | |
| ToppCell | metastatic_Brain-T/NK_cells-CD4+_Th|metastatic_Brain / Location, Cell class and cell subclass | 6.98e-05 | 189 | 52 | 4 | a2b00fbe7b7b15db3fce88a56cbac0ef2917332c | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-Activated_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.27e-05 | 191 | 52 | 4 | dabb2d0210e39455db99db155cb36a3b6af43f37 | |
| ToppCell | NS-critical-d_0-4-Myeloid-Neutrophil|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.41e-05 | 192 | 52 | 4 | 3db74359c30172a51177e00eac1f48f483e15578 | |
| ToppCell | ILEUM-inflamed-(1)_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.72e-05 | 194 | 52 | 4 | cf22bd6afe51c42cb151c37a8b65c98649dae1a4 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.72e-05 | 194 | 52 | 4 | 744fd4580942183a1058717d0c3ac86483e366ed | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.72e-05 | 194 | 52 | 4 | b04cbd240c59755ef7bdeb17fee3028caef6dedb | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.72e-05 | 194 | 52 | 4 | d2f6c8900b5c448eede8047ca964e94b19bd6ca5 | |
| ToppCell | T/NK_cells-CD8+_Effector_T_cell|T/NK_cells / Lineage and Cell class | 7.87e-05 | 195 | 52 | 4 | 9bb1281e63daf6aca2817f9cc1f55463b069909f | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-Activated_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.87e-05 | 195 | 52 | 4 | a7c70284ac47dcc6f47ee2805b76b14edfa1c0b9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.87e-05 | 195 | 52 | 4 | 562e4c0e4e81f6303e57b846da71d1667fc35963 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.87e-05 | 195 | 52 | 4 | fa8ac154e5aebc26463ff84f0ad1038095770bc6 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.03e-05 | 196 | 52 | 4 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | (07)_Ionocytes-(0)_Reference|(07)_Ionocytes / shred by cell type by condition | 8.03e-05 | 196 | 52 | 4 | 4ac33e7d11b8b0fff6ee2e9dacad49c21d63b818 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.03e-05 | 196 | 52 | 4 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | critical-Myeloid-Neutrophil|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.19e-05 | 197 | 52 | 4 | f1248781e71e3a158d06e9ec93eb90dc6d48bcb2 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-Activated_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.19e-05 | 197 | 52 | 4 | 2f2e5a5e1cb00b9e51c1a9f86d34ac65cb8b3999 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.19e-05 | 197 | 52 | 4 | 908d2bebc36f0e5bd5eae3d0fac1d3b3a9db3cdd | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.19e-05 | 197 | 52 | 4 | 037f5f26fa66818baa35846aa96336155e8a6f45 | |
| ToppCell | critical-Myeloid|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.35e-05 | 198 | 52 | 4 | a5807517f8ca93b77f49f5787fd9036178b8fc2a | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD8-MAIT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.35e-05 | 198 | 52 | 4 | 795e5ae833bbd1a3d16591195301b45eb1c113a4 | |
| ToppCell | critical-Myeloid-Neutrophil|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.35e-05 | 198 | 52 | 4 | 4da73dc3acb29d70b160903600d2bf7fdab34333 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.35e-05 | 198 | 52 | 4 | ecd93e28bae4152467f6d6621cffc73c301c9795 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-05 | 199 | 52 | 4 | cf9a4756ce0b116715685ed8c00b163d8cb887f1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-05 | 199 | 52 | 4 | a94212f27b90368513e5e0226eb53aea212fef8d | |
| ToppCell | NS-critical|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.51e-05 | 199 | 52 | 4 | f7c14dc9a9e659f89352dccf8954d6cbada011ab | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Activated_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.68e-05 | 200 | 52 | 4 | 80b35d808b26ca5021cbadbef523457ca789cd20 | |
| ToppCell | (11)_Activated_CD4_T|World / shred on Cell_type and subtype | 9.37e-05 | 204 | 52 | 4 | 5c085c5335bf69c18fa298efa137e9bf529eefc6 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1-Excitatory_Neuron.Slc17a7.Fibcd1-Lypd1_(CA1_Principal_cells_(Anterior))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.30e-04 | 84 | 52 | 3 | 52d167614afa9b056f2934142d3250fe5e70e806 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-04 | 93 | 52 | 3 | 6db0c9a276fa1e3807a82a3ecd708d3a7602d288 | |
| ToppCell | COVID-19-kidney-Epithelial_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.72e-04 | 120 | 52 | 3 | e17c85d41c781a29dec7e03a8b0637dccb4346bc | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.07e-04 | 142 | 52 | 3 | ae495c8dd733f0fde66bddc281606543f21c0d4b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-cortical_neurons_2|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 6.07e-04 | 142 | 52 | 3 | 435f39976841438690fcbf85bfa8e7f5b9e43916 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.72e-04 | 147 | 52 | 3 | 2885978bcfc5623967c0c1204dadf5c78c74a082 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.85e-04 | 148 | 52 | 3 | 80470353e12599440f711b6e107730763376d04d | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.98e-04 | 149 | 52 | 3 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.26e-04 | 151 | 52 | 3 | 535872e231ac0ee7b4fc4d02a260752cbbf50a2b | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.26e-04 | 151 | 52 | 3 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | Dendritic_Cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 7.26e-04 | 151 | 52 | 3 | e089bf197ed60e7243160521d4390d4b40a3832b | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-04 | 154 | 52 | 3 | ad6cfd7fc02f4201863dc8e12e353395c86c5fdb | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.83e-04 | 155 | 52 | 3 | 5687416773809b8c478567bc54310af102b3029a | |
| ToppCell | Monocytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 7.83e-04 | 155 | 52 | 3 | 82abfcee23ba08a1eb4208d367393285026e5388 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.13e-04 | 157 | 52 | 3 | f1c6c313836352271033d23efd31b0f0a8a09e02 | |
| ToppCell | Monocytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 8.28e-04 | 158 | 52 | 3 | c3096b3a914a1a15ebe3664613e94b951f8555fc | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-04 | 158 | 52 | 3 | 90ca742739a208d457db087655ba3d1c18a9da57 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-04 | 158 | 52 | 3 | e0b862e4b9ebaa12869640b5d18d5fa852861bef | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-04 | 158 | 52 | 3 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-04 | 160 | 52 | 3 | 8dae9b0cf90a09acb196223f45a14680102630b2 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-04 | 160 | 52 | 3 | 398f162e8a75c6cb5c3e4d1832e98d386e1f222b | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.58e-04 | 160 | 52 | 3 | bb1bb3673059768c0ea0160d29fff127f3a4ecb4 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.58e-04 | 160 | 52 | 3 | 76f49b8b4450fa8acd36326bfa36a5d1f4bd95fb | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-04 | 160 | 52 | 3 | 12aaab0291035f578e2433efd169ae72f393a5a5 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-04 | 160 | 52 | 3 | 8a7a73b0ee1877fe02d47f745d36ae2858b529e1 | |
| ToppCell | droplet-Fat-Mat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-04 | 161 | 52 | 3 | 8c62ae3fcf304db0f71633e328ceba81a70f03c4 | |
| ToppCell | lymphoid-NK_cell-TNFRSF18+IL7R-_NK_cell|NK_cell / Lineage, cell class and subclass | 8.90e-04 | 162 | 52 | 3 | 9c58ce6643d3a00f09dc89f94e5ccf8f470694b2 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.90e-04 | 162 | 52 | 3 | adf545cf9357556e2ce7affed01c2f6a24b0581d | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.06e-04 | 163 | 52 | 3 | 8a4931c9fdaedcf6c319157821d3556cd25fc9e5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.38e-04 | 165 | 52 | 3 | 50f1fa7434ebb777e15d5273d1ff41070cff6db3 | |
| ToppCell | Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, Lineage and Cell Type | 9.38e-04 | 165 | 52 | 3 | 8728f927502e56f2768b4224e9111939d3d7815a | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.55e-04 | 166 | 52 | 3 | a41a20cef053c67da2d435e3e132ce28f1661c03 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.88e-04 | 168 | 52 | 3 | de0b00bc405c898d08a06b2e585fb62c0ab9a66e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-ILC3|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.88e-04 | 168 | 52 | 3 | 4f2f78e14f044b535847bcdbbcec8c0fc8529870 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-03 | 169 | 52 | 3 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|Endothelial_cells / Location, Cell class and cell subclass | 1.04e-03 | 171 | 52 | 3 | dcb6c41980008d0b9eeb54999faff77311554976 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC1|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-03 | 171 | 52 | 3 | 04346d4eb726875e3537e215ea081a0318ca4ddd | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-03 | 171 | 52 | 3 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-03 | 171 | 52 | 3 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 172 | 52 | 3 | 6aab59add5b180cee0ca31179c620e89d352d5c1 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 172 | 52 | 3 | a125ac2db9c8ece95970a93aa6f7918d1dcef886 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-03 | 173 | 52 | 3 | 09cd878c33534bd476d6a4880f5582076189da8c | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 173 | 52 | 3 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-03 | 173 | 52 | 3 | 62abaaaf48cabd1423f17fb27c33b75ea88867f4 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 173 | 52 | 3 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 173 | 52 | 3 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-03 | 174 | 52 | 3 | 0e541581df2d4249270b28ceded6298329013580 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-03 | 174 | 52 | 3 | 09b091e24317c3f7bac043f04762a533e30793de | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-03 | 175 | 52 | 3 | 6374ab186d7ccf7f6dfb858267edba8962789e15 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-03 | 175 | 52 | 3 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-03 | 176 | 52 | 3 | 581045e61cdcdfa85701343d1a7c0a72a36606a7 | |
| ToppCell | NS-critical-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.13e-03 | 176 | 52 | 3 | 7cf1a06ceee1ec06532f44c729c31b4d58e5ea49 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-regulatory_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.13e-03 | 176 | 52 | 3 | 856a8c4211ea33d926b18d8959a03909562aa563 | |
| ToppCell | BAL-Mild-cDC_3|Mild / Compartment, Disease Groups and Clusters | 1.13e-03 | 176 | 52 | 3 | f9b0c3ced391e7ebe6b242d3f12ba14741f88d22 | |
| ToppCell | COVID-19_Severe-MAIT|COVID-19_Severe / Disease condition and Cell class | 1.15e-03 | 177 | 52 | 3 | 8eb69041f482b58325e3539f607923f7b1fa5977 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.15e-03 | 177 | 52 | 3 | 3d1b142aa2bd18df14816abaca356596b297394e | |
| ToppCell | facs-Brain_Myeloid-Striatum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 177 | 52 | 3 | efb1990fd1d216f64261e81017299783afb24a1e | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.17e-03 | 178 | 52 | 3 | 86f1741636ed3e85bb4a65f84949b718fc38c290 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.79e-04 | 50 | 24 | 3 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_MEMORY_NAIVE_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.79e-04 | 50 | 24 | 3 | GAVISH_3CA_METAPROGRAM_B_CELLS_STRESS | |
| Drug | 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1.83e-06 | 11 | 52 | 3 | ctd:D001498 | |
| Drug | verticillin | 1.53e-05 | 3 | 52 | 2 | CID003084126 | |
| Drug | tanshinone II A sodium sulfonate | 1.53e-05 | 3 | 52 | 2 | ctd:C024894 | |
| Drug | 3-methoxy-4'-methylthiostilbene | 3.06e-05 | 4 | 52 | 2 | ctd:C000601815 | |
| Drug | estradiol-16 | 3.06e-05 | 4 | 52 | 2 | ctd:C063035 | |
| Drug | eugenol, zinc oxide dental cavity lining | 3.06e-05 | 4 | 52 | 2 | ctd:C028995 | |
| Drug | thunberginol A | 3.06e-05 | 4 | 52 | 2 | ctd:C079055 | |
| Drug | cupric acetate | 3.06e-05 | 4 | 52 | 2 | ctd:C015092 | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; HL60; HT_HG-U133A | 3.50e-05 | 163 | 52 | 5 | 2145_UP | |
| Drug | diacetylcurcumin | 5.09e-05 | 5 | 52 | 2 | ctd:C493686 | |
| Drug | canventol | 5.09e-05 | 5 | 52 | 2 | CID000073256 | |
| Drug | pyro-Glu-His-Gly | 7.63e-05 | 6 | 52 | 2 | CID003918406 | |
| Drug | green tea extract AR25 | 7.63e-05 | 6 | 52 | 2 | ctd:C465546 | |
| Drug | Xanthones | 7.63e-05 | 6 | 52 | 2 | ctd:D044004 | |
| Drug | AC1L1FWT | 1.07e-04 | 7 | 52 | 2 | CID000003427 | |
| Drug | TcIP | 1.07e-04 | 7 | 52 | 2 | CID000151395 | |
| Drug | AC1L1BK6 | 1.13e-04 | 41 | 52 | 3 | CID000001473 | |
| Drug | muconaldehyde | 1.42e-04 | 8 | 52 | 2 | ctd:C034476 | |
| Drug | eupafolin | 1.42e-04 | 8 | 52 | 2 | ctd:C503624 | |
| Drug | Silicates | 1.42e-04 | 8 | 52 | 2 | ctd:D017640 | |
| Drug | 3-[(2S,3R,5R,6S)-5-hydroxy-6-methyl-3-[(2S,3R,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one | 1.42e-04 | 8 | 52 | 2 | CID011972346 | |
| Drug | 3-caffeoyl-4-dihydrocaffeoylquinic acid | 1.42e-04 | 8 | 52 | 2 | ctd:C544671 | |
| Drug | 3,4,5-triCQA | 1.42e-04 | 8 | 52 | 2 | CID006440783 | |
| Drug | isorhapontigenin | 1.42e-04 | 8 | 52 | 2 | ctd:C432307 | |
| Drug | Epoxy Compounds | 1.42e-04 | 8 | 52 | 2 | ctd:D004852 | |
| Drug | lanthanum chloride | 1.82e-04 | 9 | 52 | 2 | ctd:C028521 | |
| Drug | thunberginol B | 1.82e-04 | 9 | 52 | 2 | ctd:C079056 | |
| Drug | iododimethylarsine | 1.82e-04 | 9 | 52 | 2 | CID000069608 | |
| Drug | Bd 1047 | 1.82e-04 | 9 | 52 | 2 | CID000188914 | |
| Drug | 2-oxothiazolidine-4-carboxylic acid | 1.82e-04 | 9 | 52 | 2 | ctd:C029536 | |
| Drug | flavokawain A | 1.82e-04 | 9 | 52 | 2 | ctd:C500809 | |
| Disease | alcohol and nicotine codependence | 1.83e-04 | 13 | 46 | 2 | EFO_0004776 | |
| Disease | colorectal adenoma (is_marker_for) | 4.44e-04 | 20 | 46 | 2 | DOID:0050860 (is_marker_for) | |
| Disease | colorectal adenocarcinoma (is_marker_for) | 8.14e-04 | 27 | 46 | 2 | DOID:0050861 (is_marker_for) | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1.13e-03 | 131 | 46 | 3 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1.13e-03 | 131 | 46 | 3 | C4552091 | |
| Disease | Juvenile arthritis | 1.13e-03 | 131 | 46 | 3 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 1.13e-03 | 131 | 46 | 3 | C3714758 | |
| Disease | Cholestasis, Extrahepatic | 1.14e-03 | 32 | 46 | 2 | C0005398 | |
| Disease | Juvenile-Onset Still Disease | 1.23e-03 | 135 | 46 | 3 | C0087031 | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 1.53e-03 | 37 | 46 | 2 | DOID:0050865 (is_marker_for) | |
| Disease | Amyotrophic Lateral Sclerosis, Sporadic | 2.56e-03 | 48 | 46 | 2 | C1862941 | |
| Disease | Amyotrophic Lateral Sclerosis, Familial | 2.56e-03 | 48 | 46 | 2 | C4551993 | |
| Disease | Duchenne muscular dystrophy, disease progression measurement | 2.78e-03 | 50 | 46 | 2 | EFO_0008336, MONDO_0010679 | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 2.78e-03 | 50 | 46 | 2 | C1862939 | |
| Disease | susceptibility to common cold measurement | 3.23e-03 | 54 | 46 | 2 | EFO_0008417 | |
| Disease | Petit mal status | 4.93e-03 | 67 | 46 | 2 | C0270823 | |
| Disease | Status Epilepticus, Subclinical | 4.93e-03 | 67 | 46 | 2 | C0751522 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RKQCQVRRLREQEKM | 371 | Q8N715 | |
| IQCDALERRRIQMLK | 111 | A6NEN9 | |
| CSDIRQFCKKIRRRM | 791 | Q14203 | |
| GQMKRKYRVCNVTRR | 271 | Q9UL18 | |
| LRRCRHRMRELKQNQ | 1176 | O94983 | |
| KLERFKRMCQLLERV | 306 | Q6PCT2 | |
| RLLMRREQVLKICAN | 1231 | P49792 | |
| QVRIVMRRDQVLKLC | 1391 | Q99666 | |
| QVRIVMRRDQVLKLC | 1391 | O14715 | |
| RRKLRKHNCLQRRCM | 31 | P0DMC3 | |
| TRCLNKIMKTRVCRR | 496 | O60840 | |
| KIMKTRVCRRLRRAN | 501 | O60840 | |
| LMCQLSQEKPRVRKR | 441 | Q02779 | |
| KQLLLRNFIRMKRCV | 771 | Q6DN14 | |
| RNFIRMKRCVMVLVN | 776 | Q6DN14 | |
| RIRRERNKMAAAKCR | 141 | P01100 | |
| RNKMAAAKCRNRRRE | 146 | P01100 | |
| RQRLVKRMRCEQIKA | 16 | Q9Y6X6 | |
| MRKEDLCRKIIGRRN | 76 | P59045 | |
| ERKRMRNRIAASKCR | 256 | P05412 | |
| ARELRVSCMQRKKVQ | 46 | Q8NA75 | |
| IRDKKQLCQLQRRMH | 791 | Q5BJE1 | |
| CAKKMQLVNLRNRRV | 376 | Q5TB30 | |
| LVAMICRRRRRRKKA | 421 | Q50LG9 | |
| RQVLEKLLAKRRRMV | 46 | A8MTL0 | |
| QRVQMRLRRQKKGVV | 376 | Q8IZJ4 | |
| LMEKKLSRRLCENRR | 1061 | Q8NFC6 | |
| IVLQMVERCRIRKLQ | 46 | O60308 | |
| QLRLVCKRMDLVCQR | 86 | Q9NVF7 | |
| LRLMKNREAAKECRR | 291 | Q03060 | |
| LRERVNKRRVKEMVK | 931 | O94829 | |
| QVRIVMRRDQVLKLC | 1376 | P0DJD0 | |
| VKVVVRCRPMNQRER | 6 | Q9P2E2 | |
| QREKRRRKLLMDQLI | 306 | Q9C093 | |
| RIVMRRDQVLKLCAN | 1386 | P0DJD1 | |
| VMIARCIQHRKRLQR | 191 | Q9H6Y7 | |
| VQRNRSLLKRMLKCL | 476 | Q149N8 | |
| KQIENVVKMLRCRRG | 76 | Q6P4H8 | |
| QCKNVLKIRRRKMNH | 126 | Q9NWT8 | |
| RMIKNRESACQSRRK | 331 | Q99941 | |
| FRGNQMRLKRACIRK | 76 | Q9C0D3 | |
| VLRQCGNRVKLMIAR | 321 | O75970 | |
| LQMDELKCRKRVLRR | 846 | P42285 | |
| AEKRMATEKRQLRCR | 336 | P12524 | |
| RILMQRKKREVLARR | 231 | Q6ZNA4 | |
| MKQRDNCKIRIQRQL | 151 | O75558 | |
| EARQLKSCMKPVRRR | 321 | Q6ZSY5 | |
| SRMNKRIIEEICRKV | 1146 | Q6ZT12 | |
| RLKLERKQRRMCRRD | 61 | O14904 | |
| KLRQTFVRMLTCRKI | 291 | Q9NYW2 | |
| KLRKRLQAQRLVMRR | 201 | Q8WTV1 | |
| MERIRRHQQACLREK | 906 | Q9HAU0 | |
| RLLQKCKELMKRARQ | 811 | Q8IY18 | |
| CKQALKRNRSRMRQL | 336 | Q9UL49 | |
| VKLRRQRCLMVQVEA | 886 | P08575 |